Decreased expression of SERPINB1 correlates with tumor invasion and poor prognosis in hepatocellular carcinoma

Journal of Molecular Histology

Volumn 45, Issue 1, 2014, Pages 59-68

  Cui, Xiaopeng ^a,b   Liu, Yanhua ^b   Wan, Chunhua ^b   Lu, Cuihua ^b   Cai, Jing ^b   He, Song ^b   Ni, Tingting ^b   Zhu, Junya ^b   Wei, Lixian ^b   Zhang, Yixin ^b   Qian, Haixin ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Invasion; Prognosis; SERPINB1

Indexed keywords

GELATINASE A; SERINE PROTEASE INHIBITOR CLADE B MEMBER 1; SERINE PROTEINASE INHIBITOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; VEIN; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROGNOSIS; SERPINS; TUMOR BURDEN;

EID: 84893224575     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9529-0     Document Type: Article

References (43)

1. Askew YS, Pak SC, Luke CJ, Askew DJ, Cataltepe S, Mills D et al (2001) SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases. J Biol Chem 276(52):49320-49330
2. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ (2006) Biological functions of maspin. J Cell Physiol 209(3):617-624
3. Baker MS, Bleakley P, Woodrow GC, Doe WF (1990) Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation. Cancer Res 50(15):4676-4684
4. Bartuski AJ, Kamachi Y, Schick C, Overhauser J, Silverman GA (1997) Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3. Genomics 43(3):321-328
5. Bjorklund M, Koivunen E (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755(1):37-69
6. Canel M, Secades P, Garzon-Arango M, Garzon-Arngo M, Allonca E, Suarez C et al (2008) Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer 98(7):1274-1284
7. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559-1564
8. Chernov AV, Strongin AY (2011) Epigenetic regulation of matrix metalloproteinases and their collagen substrates in cancer. Biomol Concepts 2(3):135-147
9. Chou RH, Wen HC, Liang WG, Lin SC, Yuan HW, Wu CW et al (2012) Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides. Oncol Rep 27(1):238-245
10. Cooley J, Takayama TK, Shapiro SD, Schechter NM, Remold-O'Donnell E (2001) The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 40(51):15762-15770
11. Coughlin P, Nicholl J, Sun J, Salem H, Bird P, Sutherland GR (1995) Chromosomal mapping of the human proteinase inhibitor 6 (PI6) gene to 6p25 by fluorescence in situ hybridization. Genomics 26(2):431-433
12. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25(1):9-34
13. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161-174
14. Evans E, Cooley J, Remold-O'Donnell E (1995) Characterization and chromosomal localization of ELANH2, the gene encoding human monocyte/neutrophil elastase inhibitor. Genomics 28(2):235-240
15. Eyre HJ, Sun J, Sutherland GR, Bird P (1996) Chromosomal mapping of the gene (PI9) encoding the intracellular serpin proteinase inhibitor 9-6p25 by fluorescence in situ hybridization. Genomics 37(3):406-408
16. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z (2002) Genetic mechanisms of hepatocarcinogenesis. Oncogene 21(16):2593-2604
17. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN. Int J Cancer 127(12):2893-2917
18. Gettins PG (2002) Serpin structure, mechanism, and function. Chem Rev 102(12):4751-4804
19. Irving JA, Pike RN, Lesk AM, Whisstock JC (2000) Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 10(12):1845-1864
20. Ishikawa N, Endo Y, Sasaki T (1996) Inverse correlation between mRNA expression of plasminogen activator inhibitor-2 and lymph node metastasis in human breast cancer. Jpn J Cancer Res 87(5):480-487
21. Ito H, Yonemura Y, Fujita H, Tsuchihara K, Kawamura T, Nojima N et al (1996) Prognostic relevance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in gastric cancer. Virchows Arch 427(5):487-496
22. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
23. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52-67
24. Law RH, Zhang Q, Mc Gowan S, Buckle AM, Silverman GA, Wong W et al (2006) An overview of the serpin superfamily. Genome Biol 7(5):216
25. Liu Z, Wu X, Zhang F, Han L, Bao G, He X, Xu Z (2013) AhR expression is increased in hepatocellular carcinoma. J Mol Histol
26. Murphy G, Stanton H, Cowell S, Butler G, Knauper V, Atkinson S et al (1999) Mechanisms for pro matrix metalloproteinase activation. APMIS 107(1):38-44
27. Nakamura M, Konno H, Tanaka T, Maruo Y, Nishino N, Aoki K et al (1992) Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. Thromb Res 65(6):709-719
28. Pemberton PA, Stein PE, Pepys MB, Potter JM, Carrell RW (1988) Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336(6196):257-258
29. Potempa J, Korzus E, Travis J (1994) The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269(23):15957-15960
30. Rawlings ND, Tolle DP, Barrett AJ (2004) Evolutionary families of peptidase inhibitors. Biochem J 378(Pt 3):705-716
31. Rees DD, Rogers RA, Cooley J, Mandle RJ, Kenney DM, Remold-O'Donnell E (1999) Recombinant human Monocyte/Neutrophil elastase inhibitor protects rat lungs against injury from cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 20(1):69-78
32. Remold-O'Donnell E (1993) The ovalbumin family of serpin proteins. FEBS Lett 315(2):105-108
33. Schick C, Bromme D, Bartuski AJ, Uemura Y, Schechter NM, Silverman GA (1998) The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition. Proc Natl Acad Sci USA 95(23):13465-13470
34. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG et al (2001) Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 189(2):197-206
35. Silverman GA, Whisstock JC, Askew DJ, Pak SC, Luke CJ, Cataltepe S et al (2004) Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell Mol Life Sci 61(3):301-325
36. Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang L, Shen A (2012) Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-kappaB activation. Mol Biol Cell 23(14):2635-2644
37. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232(1):10-24
38. Wu YY, Chen L, Wang GL, Zhang YX, Zhou JM, He S, Qin J, Zhu YY (2013) Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF. J Mol Histol
39. Yang P, Yuan W, He J, Wang J, Yu L, Jin X et al (2009) Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: implications for tumor progression and prognosis. Hepatol Res 39(12):1169-1177
40. Yoshino H, Endo Y, Sasaki T (1998) Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br J Cancer 78(6):833-839
41. Zeng W, Silverman GA, Remold-O'Donnell E (1998) Structure and sequence of human M/NEI (monocyte/neutrophil elastase inhibitor), an Ov-serpin family gene. Gene 213(1-2):179-187
42. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H et al (2006) Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26(5A):3579-3583
43. Zheng J, Li Y, Yang JG, Liu Q, Shi M, Zhang R et al (2011) NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer 11(251):251-259